GB1214408A - 3,5-diamino-6-halo-pyrazinamide derivatives - Google Patents

3,5-diamino-6-halo-pyrazinamide derivatives

Info

Publication number
GB1214408A
GB1214408A GB41777/68A GB4177768A GB1214408A GB 1214408 A GB1214408 A GB 1214408A GB 41777/68 A GB41777/68 A GB 41777/68A GB 4177768 A GB4177768 A GB 4177768A GB 1214408 A GB1214408 A GB 1214408A
Authority
GB
United Kingdom
Prior art keywords
alkyl
phenyl
group
alkoxy
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB41777/68A
Inventor
Edward Jethro Cragoe Jr
Kenneth Leroy Shepard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of GB1214408A publication Critical patent/GB1214408A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/24Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D241/26Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with nitrogen atoms directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

1,214,408. 3,5 - Diamino - 6 - halo - pyrazinamide derivatives. MERCK & CO. Inc. 3 Sept., 1968 [7 Sept., 1967; 21 March, 1968], No. 41777/68. Heading C2C. [Also in Division A5] 3,5 - Diamino - 6 - halo - pyrazinamide derivatives of the general formula wherein R<SP>1</SP> is a hydrogen atom or a C 1-5 alkyl, C 3-5 alkenyl, C 3-5 alkynyl, C 3-6 cycloalkyl, C 3-6 cycloalkyl-C 1-3 alkyl, di(C 1-3 alkyl)amino-methyl-C 1-3 alkyl, (hydroxy-C 1-5 alkyl)methyl, (polyhydroxy - C 1-5 alkyl) - methyl, #, #, # - trifluoro-C 1-3 alkyl, phenyl-C 1-3 alkyl, halophenyl- C 1-3 alkyl, heterocyclic-C 1-3 alkyl in which the heterocyclic moiety is a 5- or 6-membered ring containing oxygen or nitrogen or both, phenyl, halophenyl, C 1-3 alkyl-phenyl, C 1-3 alkoxy, phenyl-C 1-3 alkoxy or amino group; and R<SP>2</SP> is a hydrogen atom or a C 1-5 alkyl group; or R<SP>1</SP> and R<SP>2</SP> are alkylene groups linked together directly or through a hetero atom to form a heterocyclic structure with the nitrogen atom to which they are attached; Y is a chlorine, bromine or iodine atom; and R<SP>6</SP> is a C 1-5 alkyl, C 1-3 alkoxymethyl-C 1-5 alkyl, cyano.C 1-5 alkyl, (C 1-3 alkoxy)carbonyl-C 1-5 alkyl, phenyl-C 1-5 alkyl, di-(C 1-3 alkyl)aminomethyl-C 1-5 alkyl, 2 - (2 - imidazolinyl) - amino - methyl - C 1-5 alkyl, 1-pyrrolidinyl-C 1-5 alkyl, piperidino-C 1-5 alkyl, hexahydro-1-azepinyl-C 1-5 alkyl, morpholino-C 1-5 alkyl, 4-(C 1-3 alkyl)-1 -piperazinyl-C 1-5 alkyl, pyridyl-C 1-5 alkyl, faryl-C 1-5 alkyl, tetrahydropyranyl-C 1-5 alkyl, C 3-5 alkenyl, C 3-5 alkynyl, phenyl, halophenyl, C 1-3 alkyl-phenyl, C 1-3 alkoxy-phenyl, cyano, amino, di(C 1-3 alkyl)- amino, N-C 1-3 alkyl-N-(phenyl - C 1-3 alkyl)- amino, di[phenyl- (C 1-3 alkyl)]amino, pyridylamino, pyrimidinylamino, quinolinylamino, pyrrolidino, piperidino, hexahydro-1-azepinyl, morpholino or 4-(3,5-diamino- 1,2,4-triazolyl) group; a group of the formula in which R<SP>7</SP> is a C 1-5 alkyl, phenyl, halophenyl, C 1-3 alkyl-phenyl or C 1-3 alkoxy-phenyl group; a group of the formula in which R<SP>8</SP> is a hydrogen atom or a phenyl or C 1-5 alkyl group, R<SP>9</SP> is a hydrogen atom or a C 1-5 alkyl, hydroxy-C 1-5 alkyl, phenyl-C 1-5 alkyl, halophenyl-C 1-5 alkyl, (C 1-3 alkyl)-phenyl- C 1-5 alkyl, (C 1-3 alkoxy)-phenyl-C 1-5 alkyl, naphthyl-C 1-5 alkyl, balonaphthyl-C 1-5 alkyl, (C 1-3 alkyl) - naphthyl - C 1-5 alkyl, (C 1-3 alkoxy) - naphthyl - C 1-5 alkyl, pyridyl - C 1-5 alkyl, morpholino-C 1-5 alkyl, furyl-C 1-5 alkyl, 1 - pyrrolidyl - C 1-5 alkyl, C 1-3 alkoxy-C 1-5 alkyl, C 3-5 alkenyl, C 2-5 alkylideneamino, (phenyl - C 2-5 alkylidene)amino, hydroxy, phenyl, C 1-3 alkyl-phenyl, C 1-3 alkoxy-phenyl, halophenyl, C 1-3 alkoxy or phenyl-C 1-3 alkoxy group and R<SP>10</SP> is a hydrogenation or a C 1-5 alkyl group, or R<SP>9</SP> and R<SP>10</SP> are alkylene groups linked together to form, with the nitrogen atom to which they are attached, a heterocyclic ring containing from 5 to 8 atoms, optionally including a further heteroatom, or R<SP>8</SP> and R<SP>9</SP> are alkylene groups linked together to form, with the nitrogen atom to which they are attached, a heterocyclic ring containing from 5 to 7 ring atoms; a group of the formula in which R<SP>11</SP> is an hydrogen atom or a C 1-5 alkyl group, R<SP>12</SP> is a hydrogen atom or a C 1-5 alkyl, hydroxy-C 1-5 alkyl, phenyl-C 1-5 alkyl, halophenyl-C 1-5 alkyl, (C 1-3 alkyl)-phenyl-C 1-5 alkyl, phenyl, halophenyl, C 1-3 alkyl-phenyl, C 1-3 alkoxy-phenyl or amino group and R<SP>13</SP> is a hydrogen atom, or R<SP>11</SP> and R<SP>13</SP> are alkylene groups linked together to form a diazacyclic ring containing from 5 to 7 ring atoms with the nitrogen atoms to which they are attached; are prepared by reaction of a 3,5-diamino-6-halopyrazinoyloxyacrylamide of the general formula wherein R<SP>3</SP> is a methyl, ethyl, n-propyl, isopropyl, phenyl, (C 1-3 alkyl)-phenyl or sulphophenyl group, in which case an internal salt is formed with an amino group; and R<SP>4</SP> is a hydrogen atom; or R<SP>3</SP> and R<SP>4</SP> are linked to form an o-phenylene group with the carbon atom to which R<SP>3</SP> and R<SP>4</SP> are attached; R<SP>5</SP> is a C 1-5 alkyl group; with an amine of the general formula R<SP>6</SP>NH 2 . Certain of the 3,5-diamino-6- halo-pyrazinamide derivatives of the first general formula above are novel.
GB41777/68A 1967-09-07 1968-09-03 3,5-diamino-6-halo-pyrazinamide derivatives Expired GB1214408A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US66600467A 1967-09-07 1967-09-07
US71897668A 1968-03-21 1968-03-21

Publications (1)

Publication Number Publication Date
GB1214408A true GB1214408A (en) 1970-12-02

Family

ID=27099350

Family Applications (2)

Application Number Title Priority Date Filing Date
GB41777/68A Expired GB1214408A (en) 1967-09-07 1968-09-03 3,5-diamino-6-halo-pyrazinamide derivatives
GB53830/69A Expired GB1214409A (en) 1967-09-07 1968-09-03 Novel pyrazine derivatives and their preparation

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB53830/69A Expired GB1214409A (en) 1967-09-07 1968-09-03 Novel pyrazine derivatives and their preparation

Country Status (15)

Country Link
AT (1) AT289123B (en)
BE (1) BE720233A (en)
CA (1) CA939345A (en)
CH (1) CH534168A (en)
DK (1) DK145892C (en)
ES (1) ES357877A1 (en)
FI (1) FI50975C (en)
FR (1) FR8490M (en)
GB (2) GB1214408A (en)
IL (1) IL30634A0 (en)
NL (1) NL6812003A (en)
NO (1) NO125678B (en)
OA (1) OA02886A (en)
SE (1) SE355811B (en)
YU (2) YU205268A (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013064451A1 (en) * 2011-11-02 2013-05-10 Boehringer Ingelheim International Gmbh Novel process for the preparation of acylguanidines and acylthioureas
US8759349B2 (en) 2011-11-02 2014-06-24 Boehringer Ingelheim International Gmbh Heterocyclic compounds, medicaments containing said compounds, use thereof and processes for the preparation thereof
US8841309B2 (en) 2012-09-24 2014-09-23 Boehringer Ingelheim International Gmbh Substituted pyrazines and their use in the treatment of disease
US8859559B2 (en) 2011-12-20 2014-10-14 Boehringer Ingelheim International Gmbh Substituted pyrazines and their use in the treatment of disease
US9078909B2 (en) 2012-05-25 2015-07-14 Boehringer Ingelheim International Gmbh Tertiary amines, medicaments containing said amines, use thereof and processes for the preparation thereof

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013064451A1 (en) * 2011-11-02 2013-05-10 Boehringer Ingelheim International Gmbh Novel process for the preparation of acylguanidines and acylthioureas
US8759349B2 (en) 2011-11-02 2014-06-24 Boehringer Ingelheim International Gmbh Heterocyclic compounds, medicaments containing said compounds, use thereof and processes for the preparation thereof
US8791260B2 (en) 2011-11-02 2014-07-29 Boehringer Ingelheim International Gmbh Process for the preparation of acylguanidines and acylthioureas
CN104024231A (en) * 2011-11-02 2014-09-03 勃林格殷格翰国际有限公司 Novel process for the preparation of acylguanidines and acylthioureas
US9920035B2 (en) 2011-11-02 2018-03-20 Boehringer Ingelheim International Gmbh Heterocyclic compounds, medicaments containing said compounds, use thereof and processes for the preparation thereof
US8859559B2 (en) 2011-12-20 2014-10-14 Boehringer Ingelheim International Gmbh Substituted pyrazines and their use in the treatment of disease
US9078909B2 (en) 2012-05-25 2015-07-14 Boehringer Ingelheim International Gmbh Tertiary amines, medicaments containing said amines, use thereof and processes for the preparation thereof
US8841309B2 (en) 2012-09-24 2014-09-23 Boehringer Ingelheim International Gmbh Substituted pyrazines and their use in the treatment of disease

Also Published As

Publication number Publication date
SE355811B (en) 1973-05-07
ES357877A1 (en) 1970-05-01
IL30634A0 (en) 1968-10-24
GB1214409A (en) 1970-12-02
YU34082B (en) 1978-12-31
NO125678B (en) 1972-10-16
DK145892B (en) 1983-04-05
DK145892C (en) 1983-09-12
YU205268A (en) 1978-06-30
FI50975C (en) 1976-09-10
CA939345A (en) 1974-01-01
BE720233A (en) 1969-02-28
AT289123B (en) 1971-04-13
FI50975B (en) 1976-05-31
NL6812003A (en) 1969-03-11
FR8490M (en) 1973-07-27
CH534168A (en) 1973-02-28
OA02886A (en) 1970-12-15

Similar Documents

Publication Publication Date Title
GB1262411A (en) New phenoxy-aminopropanol derivatives, the preparation thereof and pharmaceutical compositions containing them
GB1058822A (en) 3-amino-2-hydroxypropoxy heterocyclic derivatives
GB1167562A (en) Novel 3-(2-Substituted Ethyl)Indoles and Processes for Their Manufacture
KR920008017A (en) Piperazine Derivatives
GB1086192A (en) Phenylcyclopropane derivatives
ES8705884A1 (en) Pyridazinones, their preparation and pharmaceutical compositions containing them.
GB1214408A (en) 3,5-diamino-6-halo-pyrazinamide derivatives
ES340591A1 (en) 1-(alpha-pyrryl)-2-amino ethanols
KR890000481A (en) Tricyclic Pyridone Derivatives
KR900015738A (en) Intraocular pressure lowering agents
ES420253A1 (en) Derivatives of 2-aminoindane thereof
GB1355718A (en) 2-amino-5-chloro-thiazole derivatives
GB1322451A (en) 3-amino-5-benzyl-1,2,4-oxadiazoles
ES478691A1 (en) Bis-triazinylaminostilbene compounds and their use as fluorescent brightening agents
GB1096351A (en) Improvements in or relating to piperazine derivatives
GB1061571A (en) N,n&#39;-disubstituted piperazines and process for their manufacture
ES472544A1 (en) 2,6-Diamino-benzo[1,2-d:5,4-d&#39;]bisthiazoles and salts thereof
GB1160064A (en) Indole Derivatives
ES352647A1 (en) 2-(4&#39;-chloro-naphthyl(1&#39;)-methyl)-imidazoline
ES352528A1 (en) Phenazine derivatives
GB1319840A (en) Substituted 5-amino imidazoles
GB1501368A (en) Triazino benzodiazepines
GB1204946A (en) Improvements in or relating to sulphon anilides and the manufacture thereof
GB1203430A (en) Heterocyclic spiro compounds
ES308890A1 (en) Benzene derivatives

Legal Events

Date Code Title Description
CSNS Application of which complete specification have been accepted and published, but patent is not sealed